Managed care
Southern California Permanente Medical Group
Southern California Permanente Medical Group was paid $20.06M by Medicaid between Jan 2018 and Dec 2024, across 276 billing codes. Its largest line is 99284, emergency room visit (serious) — 20% of everything it billed.
33Billing provider infoSOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
HARBOR CITY, CA 90710
HARBOR CITY, CA 90710
33aNPI1598797011assigned 07/07/2006
33bProvider typeHealth Maintenance Organization
28Total paid$20.06M
24GClaims764,412
24DCodes billed276
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#11 of 151
Median peer was paid$59K
This provider vs. median340×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 83,931 | $156K | |
| 2019 | 97,660 | $388K | |
| 2020 | 63,359 | $1.18M | |
| 2021 | 95,787 | $2.62M | |
| 2022 | 106,221 | $3.09M | |
| 2023 | 139,705 | $5.22M | |
| 2024incomplete | 177,749 | $7.41M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 47,958 | 47,431 | $4.10M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 61,599 | 60,453 | $3.88M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 6.1% | 23,552 | 18,733 | $1.23M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.6% | 69,360 | 67,817 | $921K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.3% | 3,968 | 2,871 | $672K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.3% | 17,391 | 17,186 | $669K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.9% | 8,512 | 8,497 | $580K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.4% | 74,399 | 74,224 | $485K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.9% | 17,053 | 11,746 | $384K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.6% | 5,815 | 5,812 | $323K |
| 90662 | 1.6% | 2,853 | 2,847 | $314K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.4% | 10,678 | 8,467 | $282K |
264 more codes
| 92015 | Determination of refractive state | 1.3% | 29,639 | $257K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 26,320 | $245K |
| 67028 | Intravitreal injection of a pharmacologic agent | 1.2% | 1,192 | $243K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.2% | 4,403 | $241K |
| 77080 | 1.1% | 6,934 | $215K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.0% | 15,474 | $204K |
| 90837 | Psychotherapy session, about an hour | <1% | 4,520 | $192K |
| 0002A | <1% | 4,408 | $171K | |
| 0001A | <1% | 4,363 | $169K | |
| 73562 | <1% | 8,538 | $161K | |
| 99285 | Emergency room visit (most serious) | <1% | 1,739 | $155K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 583 | $145K |
| 90686 | <1% | 30,485 | $145K | |
| 71045 | Radiologic examination, chest; single view | <1% | 22,251 | $124K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,646 | $120K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,186 | $117K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,024 | $102K |
| 0064A | <1% | 2,453 | $102K | |
| 92134 | <1% | 3,487 | $98K | |
| 0012A | <1% | 2,515 | $95K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,803 | $94K |
| 0124A | <1% | 2,693 | $93K | |
| 0011A | <1% | 2,439 | $87K | |
| 99441 | <1% | 4,837 | $86K | |
| 73030 | <1% | 4,523 | $84K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 9,323 | $83K |
| 73630 | <1% | 6,969 | $83K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 4,281 | $82K |
| 92557 | <1% | 1,805 | $80K | |
| 11721 | <1% | 784 | $70K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 839 | $68K |
| 99442 | <1% | 1,118 | $63K | |
| 0134A | <1% | 1,684 | $62K | |
| 92551 | <1% | 20,809 | $60K | |
| 91320 | <1% | 296 | $59K | |
| 72100 | <1% | 2,904 | $56K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 192 | $51K |
| 20610 | <1% | 628 | $50K | |
| 73610 | <1% | 3,870 | $47K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 3,900 | $47K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 563 | $47K |
| 0004A | <1% | 1,144 | $46K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 694 | $44K |
| 0054A | <1% | 1,007 | $42K | |
| 73130 | <1% | 2,877 | $42K | |
| 92567 | <1% | 2,752 | $40K | |
| 0071A | <1% | 904 | $37K | |
| 76641 | <1% | 921 | $35K | |
| 83921 | <1% | 1,160 | $35K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,299 | $33K |
| J7999 | Compounded drug, not otherwise classified | <1% | 612 | $32K |
| 86360 | <1% | 692 | $32K | |
| 73502 | <1% | 708 | $30K | |
| 0072A | <1% | 716 | $29K | |
| 90674 | <1% | 1,617 | $27K | |
| 77065 | Tomosynthesis, mammo | <1% | 435 | $26K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,908 | $26K |
| 86359 | <1% | 692 | $26K | |
| 73110 | <1% | 1,594 | $25K | |
| 73140 | <1% | 2,076 | $24K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,402 | $24K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 853 | $24K |
| 81513 | <1% | 314 | $24K | |
| 0031A | <1% | 634 | $23K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,698 | $23K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 303 | $23K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 4,020 | $23K |
| 76830 | Ultrasound, transvaginal | <1% | 1,595 | $23K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 7,555 | $22K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,591 | $21K |
| 92002 | <1% | 672 | $21K | |
| 90480 | <1% | 370 | $21K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,237 | $21K |
| 90656 | <1% | 3,496 | $20K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,430 | $20K |
| 97161 | <1% | 233 | $19K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 382 | $17K |
| 92227 | <1% | 1,870 | $17K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 844 | $17K |
| 73100 | <1% | 1,312 | $17K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 177 | $16K |
| 92523 | <1% | 192 | $14K | |
| 81329 | <1% | 593 | $13K | |
| 43775 | <1% | 27 | $13K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,187 | $12K |
| 73522 | <1% | 214 | $12K | |
| 0154A | <1% | 286 | $11K | |
| 72050 | <1% | 361 | $10K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 89 | $10K |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 186 | $10K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 272 | $9K |
| 73564 | <1% | 346 | $9K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 68 | $9K |
| 72040 | <1% | 295 | $8K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 16,936 | $8K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 45 | $8K |
| 73660 | <1% | 456 | $7K | |
| 99173 | <1% | 13,150 | $7K | |
| 73590 | <1% | 494 | $7K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 406 | $7K |
| 97166 | <1% | 405 | $6K | |
| 90651 | <1% | 295 | $6K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 48 | $6K |
| 90734 | <1% | 94 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,966 | $5K |
| 98968 | <1% | 310 | $5K | |
| 51798 | <1% | 294 | $5K | |
| 74018 | <1% | 439 | $5K | |
| 73560 | <1% | 193 | $5K | |
| 97162 | <1% | 52 | $5K | |
| 85027 | <1% | 1,256 | $5K | |
| 99223 | Prolong inpt eval add15 m | <1% | 131 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,617 | $5K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 558 | $5K |
| 73070 | <1% | 360 | $5K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 616 | $5K |
| 97597 | <1% | 28 | $4K | |
| 99443 | <1% | 74 | $4K | |
| 71101 | <1% | 137 | $4K | |
| 0074A | <1% | 117 | $4K | |
| 88307 | <1% | 81 | $4K | |
| 62323 | <1% | 25 | $4K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 43 | $4K |
| 72070 | <1% | 168 | $3K | |
| 90677 | <1% | 111 | $3K | |
| 90750 | <1% | 36 | $3K | |
| 82105 | <1% | 527 | $3K | |
| 96415 | <1% | 24 | $3K | |
| 0052A | <1% | 79 | $3K | |
| 99177 | <1% | 2,153 | $3K | |
| 73080 | <1% | 153 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 209 | $3K |
| 17110 | <1% | 38 | $3K | |
| 90694 | <1% | 25 | $3K | |
| 0051A | <1% | 59 | $2K | |
| 99219 | <1% | 12 | $2K | |
| 82565 | <1% | 1,401 | $2K | |
| 84460 | <1% | 1,053 | $2K | |
| 0081A | <1% | 53 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 56 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 142 | $2K |
| 0082A | <1% | 52 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 75 | $2K |
| 88304 | <1% | 350 | $2K | |
| 99234 | <1% | 42 | $2K | |
| 81002 | <1% | 1,339 | $2K | |
| 80051 | <1% | 871 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 28 | $2K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 201 | $2K |
| 73090 | <1% | 153 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 24 | $1K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 16 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 325 | $1K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 30 | $1K |
| 90670 | <1% | 251 | $1K | |
| 0013A | <1% | 27 | $1K | |
| 0111A | <1% | 28 | $1K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 359 | $1K |
| 76536 | <1% | 43 | $1K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 13 | $925.00 |
| 92133 | <1% | 35 | $909.00 | |
| 11900 | <1% | 26 | $901.01 | |
| 76801 | <1% | 25 | $890.81 | |
| 76380 | <1% | 12 | $795.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 26 | $780.00 |
| 90648 | <1% | 393 | $760.66 | |
| 90723 | <1% | 150 | $758.00 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 12 | $746.39 |
| 73600 | <1% | 29 | $713.88 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 19 | $693.00 |
| 0112A | <1% | 20 | $693.00 | |
| 82962 | <1% | 140 | $692.31 | |
| 99460 | <1% | 286 | $561.33 | |
| 81206 | <1% | 13 | $555.00 | |
| 73620 | <1% | 20 | $550.00 | |
| 0034A | <1% | 13 | $547.80 | |
| 76770 | <1% | 16 | $540.00 | |
| 92587 | <1% | 37 | $518.00 | |
| 90710 | <1% | 12 | $470.00 | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 30 | $448.70 |
| 92579 | <1% | 62 | $448.18 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 338 | $420.38 |
| 72220 | <1% | 15 | $420.00 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 14 | $390.00 |
| 72081 | <1% | 29 | $340.00 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 22 | $325.00 |
| 73060 | <1% | 15 | $320.00 | |
| 81025 | <1% | 165 | $282.77 | |
| 90715 | <1% | 36 | $280.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 123 | $269.94 |
| 87081 | <1% | 81 | $264.26 | |
| 87305 | <1% | 16 | $227.14 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | <1% | 49 | $224.00 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 12 | $214.00 |
| 88342 | <1% | 12 | $208.10 | |
| 87338 | <1% | 68 | $201.60 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 48 | $200.16 |
| 82677 | <1% | 12 | $170.24 | |
| 90633 | <1% | 89 | $169.00 | |
| 99305 | <1% | 12 | $154.74 | |
| 84311 | <1% | 16 | $152.84 | |
| 90696 | <1% | 12 | $136.00 | |
| 73120 | <1% | 12 | $135.36 | |
| 99417 | Prolong home eval add 15m | <1% | 13 | $112.50 |
| 90655 | <1% | 28 | $112.00 | |
| 76813 | <1% | 31 | $98.05 | |
| 99307 | <1% | 39 | $67.92 | |
| 77072 | <1% | 36 | $40.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 26 | $35.00 |
| 96127 | <1% | 30 | $30.80 | |
| 85610 | <1% | 77 | $20.94 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 25 | $20.76 |
| 81003 | <1% | 39 | $1.96 | |
| G9920 | Screening performed and negative | <1% | 3,914 | $0.12 |
| 1036F | 0% | 17,631 | $0.00 | |
| 82043 | 0% | 318 | $0.00 | |
| 99024 | 0% | 519 | $0.00 | |
| 96111 | 0% | 79 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 57 | $0.00 |
| 82040 | 0% | 48 | $0.00 | |
| 86780 | 0% | 29 | $0.00 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 23 | $0.00 |
| 82728 | 0% | 54 | $0.00 | |
| 87088 | 0% | 359 | $0.00 | |
| 3044F | 0% | 1,756 | $0.00 | |
| 83550 | 0% | 51 | $0.00 | |
| 84075 | 0% | 89 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 336 | $0.00 |
| 95117 | 0% | 13 | $0.00 | |
| 84153 | 0% | 28 | $0.00 | |
| 82607 | 0% | 30 | $0.00 | |
| 84132 | 0% | 107 | $0.00 | |
| 86803 | 0% | 12 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 12 | $0.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 18 | $0.00 |
| 99051 | 0% | 17,454 | $0.00 | |
| 80061 | Lipid panel | 0% | 409 | $0.00 |
| 87186 | 0% | 80 | $0.00 | |
| 84439 | 0% | 94 | $0.00 | |
| 90658 | 0% | 43 | $0.00 | |
| 99201 | 0% | 37 | $0.00 | |
| 3046F | 0% | 77 | $0.00 | |
| 84520 | 0% | 103 | $0.00 | |
| 82247 | 0% | 96 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 57 | $0.00 |
| 96116 | 0% | 13 | $0.00 | |
| 3051F | 0% | 114 | $0.00 | |
| 82274 | 0% | 125 | $0.00 | |
| 82947 | 0% | 100 | $0.00 | |
| 83718 | 0% | 13 | $0.00 | |
| 84450 | 0% | 52 | $0.00 | |
| 84100 | 0% | 15 | $0.00 | |
| 84295 | 0% | 37 | $0.00 | |
| 83540 | 0% | 75 | $0.00 | |
| 90849 | 0% | 15 | $0.00 | |
| 82310 | 0% | 90 | $0.00 | |
| 90661 | 0% | 162 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 26 | $0.00 |
| 84550 | 0% | 13 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 13 | $0.00 |
| 82465 | 0% | 13 | $0.00 | |
| 83721 | 0% | 31 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 14 | $0.00 |
| 99310 | Prolong nursin fac eval 15m | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.